Placenta accreta and methotrexate therapy: Three case reports

Journal of Perinatology

Volumn 20, Issue 5, 2000, Pages 331-334

  Mussalli, George M ^a,c   Shah, Jelpa ^b   Berck, David J ^a   Elimian, Andrew ^b   Tejani, Nergesh ^b   Manning, Frank A ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; BLADDER; CASE REPORT; FEMALE; HUMAN; PLACENTA ACCRETA; PREGNANCY; TREATMENT OUTCOME; UTERUS BLEEDING; VASCULAR DISEASE; VASCULARIZATION;

ADULT; FEMALE; HUMANS; METHOTREXATE; PLACENTA ACCRETA; PREGNANCY; TREATMENT OUTCOME; URINARY BLADDER; UTERINE HEMORRHAGE; VASCULAR DISEASES;

EID: 0034219037     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200373     Document Type: Article

References (16)

1. Eltabbakh GH, Watson JD. Postpartum hysterectomy. Int J Gynecol Obstet 1995; 50:257-62.
2. Leaphart WL, Schapiro U, Broome J, Welander CE, Bernstein IM. Placenta previa percreta with bladder invasion. Obstet Gynecol 1997;89:834-5.
3. Arulkumaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand 1986;65:285-6.
4. Raziel A, Golan A, Ariely S, Herman A, Caspi E. Repeated ultrasonography and intramuscular methotrexate in the conservative management of residual adherent placenta. J Clin Ultrasound 1992;20:288-90.
5. Bakri YN, Rifai A, Legarth J. Placenta previa-percreta: magnetic resonance imaging findings and methotrexate therapy after hysterectomy. Am J Obstet Gynecol 1993;169:213-4.
6. Legro RS, Price FV, Hill LM, Caritis SN. Nonsurgical management of placenta percreta: a case report. Obstet Gynecol 1994;83:847-9.
7. Jaffe R, DuBeshter B, Sherer DM, Thompson EA, Woods JR. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol 1994;171:558-9.
8. Buckshee K, Dadhwal V. Medical management of placenta accreta. Int J Gynecol Obstet 1997;59:47-8.
9. Gupta D, Sinha R. Management of placenta accreta with oral methotrexate. Int J Gynecol Obstet 1997;60:171-3.
10. Gibb DM, Soothill PW, Ward KJ. Conservative management of placenta accreta. Br J Obstet Gynecol 1994;101:79-80.
11. Komulainen MH, Vtmyrynen MA, Saarikoski S. Two cases of placenta accreta managed conservatively. Eur J Obstet Gynecol Reprod Biol 1995;62:135-7.
12. Hollander DI, Pupkin MJ, Crenshaw MC, Nagey DA. Conservative management of placenta accreta: a case report. J Reprod Med 1988;33:74-8.
13. Ananth CV, Smulian JC, Vintzileous AM. The association of placenta previa with history ofcesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997;177:1071-8.
14. Chattopadhyay SK, Kharif H, Sherbeeni MM. Placenta praevia and accreta after previous caesarean section. Eur J Obstet Gynecol Reprod Biol 1993;52: 151-6.
15. Creinin MD, Krohn MA. Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion. Am J Obstet Gynecol 1997;177:1444-9.
16. Lipscomb GH, Bran D, McCord ML, Portera JC, Ling FW. Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet Gynecol 1998;178:1354-8.